STOCK TITAN

IQM Quantum Computers Oyj (IQMX) 424B Filings

IQMX NASDAQ

Here are the 424B prospectus supplements from IQM Quantum Computers Oyj (IQMX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow IQMX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IQMX filings page.

Rhea-AI Summary

IQM Quantum Computers Oyj’s supplement updates registration for up to 8,624,989 ordinary shares issuable upon exercise of public warrants; up to 4,298,339 ordinary shares represented by ADSs; up to 3,905,981 private placement warrants and up to 3,905,981 ordinary shares issuable upon their exercise; and up to 4,306,845 ordinary shares represented by ADSs offered by selling securityholders. It also provides the company’s third-quarter and first-nine-month 2026 update.

Nine-month revenue was EUR 17.7 million, up 49% from EUR 11.9 million a year earlier. Order backlog was EUR 102.5 million as of September 30, 2026, of which EUR 59.5 million was expected to be recognized as revenue within 12 months. Third-quarter revenue was EUR 8.9 million, up 51% year over year.

Cash and cash equivalents were EUR 260.4 million as of September 30, 2026. The nine-month operating loss was EUR 231.8 million and net loss was EUR 227.5 million; operating loss included a one-time, non-cash EUR 127.1 million share-listing expense. Operating cash outflow was EUR 98.5 million. Based on current forecasts, management said existing resources were sufficient for at least the next 12 months from September 30, 2026, and the company reiterated full-year 2026 guidance.

Rhea-AI Summary

IQM Quantum Computers Oyj (IQMX), a Finland-based developer of superconducting quantum computers delivered on-premises and via cloud access, files a prospectus covering both primary issuance and resale of securities tied to its prior business combination with Real Asset Acquisition Corp. The company’s IQM ADSs trade on Nasdaq and Nasdaq Helsinki under “IQMX,” and its Public Warrants under “IQMXW.”

The registration covers 8,624,989 IQM Shares (represented by ADSs) issuable upon exercise of Public Warrants at $11.50 per share; IQM would receive up to about $99.2 million in cash if all Public Warrants are exercised, for general corporate purposes. It also registers for resale an aggregate of 12,511,165 IQM Shares and 3,905,981 Private Placement Warrants held by PIPE investors, the SPAC sponsor and insiders, from which IQM will receive no proceeds. IQM highlights its status as an emerging growth company and foreign private issuer and discloses substantial operating losses, heavy reliance on public-sector customers, supply-chain and competitive risks, and the need for significant additional capital as quantum markets and technology remain early-stage and uncertain.